SPRO
Spero Therapeutics, Inc. · Healthcare
Aquilo Capital Management, LLC bought $3.9M of Spero Therapeutics, Inc.
10% owner
Bought$3,862,898
$15.42Price
250,493Shares
+5%Stake
What SPRO did for a copier
- $1,000 copied at Mon, Jan 3 close, $15.15
- $659
- S&P 500, same days
- −6.6%
Measured over 30 trading days, to the Feb 15 close.
Aquilo Capital Management, LLC's record
12 other buys with 3 months of prices since 2021: on average −59.1% against the S&P 500, and 0 of 12 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Dec 29. Filed Mon, Jan 3, 2:46 PM ET, during the session. Returns use the Jan 3 close and the Feb 15 close. Not investment advice.